
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health is in a precarious position, with concerns about its ability to evolve in rapidly commoditizing markets and declining pricing power. However, its ubiquitous virtual care platform and ability to deliver whole-person care give it a unique advantage in the market, and its push towards whole-person health could provide a new source of revenue potential. The company's plans to mitigate gross margin pressures through operational cuts and growth could help restore its preeminence, but there is concern about the impact on key functions and pricing power. Their target price is $9 based on a 10x multiple of CY26E Integrated Care segment adjusted EBITDA and the potential for margin pressure suggests a lack of pricing power.
Bears say
Teladoc Health is a market leader in virtual healthcare solutions, with a platform that connects patients, providers, and healthcare systems. While the company has strong growth potential in areas such as its insurance offering and international expansion, its slower growth in its BetterHelp segment could hinder its overall enterprise success. Additionally, fluctuations in membership and impact of ACA subsidies expiration on Integrated Care revenue may cause volatility in growth. With a reasonable valuation and potential optionality, there may be signs of long-term growth upside, but lack of clarity on transitory factors warrants a cautious outlook.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares